AVANOS MEDICAL, INC. Quarterly Debt-to-equity in % from Q2 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Avanos Medical, Inc. quarterly Debt-to-equity history and growth rate from Q2 2015 to Q2 2024.
  • Avanos Medical, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 37.3 %, a 1.06% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 37.3 +0.39 +1.06% Jun 30, 2024
Q1 2024 37.1 -0.97 -2.55% Mar 31, 2024
Q4 2023 36.6 -3.16 -7.95% Dec 31, 2023
Q3 2023 37 +0.28 +0.76% Sep 30, 2023
Q2 2023 36.9 +3.65 +11% Jun 30, 2023
Q1 2023 38 +7.35 +23.9% Mar 31, 2023
Q4 2022 39.8 +11.3 +39.6% Dec 31, 2022
Q3 2022 36.7 +6.53 +21.6% Sep 30, 2022
Q2 2022 33.2 -0.22 -0.66% Jun 30, 2022
Q1 2022 30.7 -5.12 -14.3% Mar 31, 2022
Q4 2021 28.5 -9.51 -25% Dec 31, 2021
Q3 2021 30.2 -10.1 -25% Sep 30, 2021
Q2 2021 33.4 -7.63 -18.6% Jun 30, 2021
Q1 2021 35.8 -5.37 -13% Mar 31, 2021
Q4 2020 38 -3.9 -9.31% Dec 31, 2020
Q3 2020 40.3 -1.48 -3.55% Sep 30, 2020
Q2 2020 41.1 -0.47 -1.13% Jun 30, 2020
Q1 2020 41.2 -2.69 -6.13% Mar 31, 2020
Q4 2019 41.9 -9.94 -19.2% Dec 31, 2019
Q3 2019 41.7 -19.7 -32.1% Sep 30, 2019
Q2 2019 41.5 -30 -41.9% Jun 30, 2019
Q1 2019 43.9 -36.6 -45.5% Mar 31, 2019
Q4 2018 51.8 -30.8 -37.3% Dec 31, 2018
Q3 2018 61.5 -23 -27.2% Sep 30, 2018
Q2 2018 71.6 -15 -17.3% Jun 30, 2018
Q1 2018 80.5 -8.57 -9.62% Mar 31, 2018
Q4 2017 82.7 -7.08 -7.89% Dec 31, 2017
Q3 2017 84.5 -5.7 -6.32% Sep 30, 2017
Q2 2017 86.5 -4.26 -4.69% Jun 30, 2017
Q1 2017 89.1 +7.89 +9.72% Mar 31, 2017
Q4 2016 89.8 +13.8 +18.1% Dec 31, 2016
Q3 2016 90.2 +18.7 +26.1% Sep 30, 2016
Q2 2016 90.8 +39.5 +77.1% Jun 30, 2016
Q1 2016 81.2 Mar 31, 2016
Q4 2015 76 Dec 31, 2015
Q3 2015 71.5 Sep 30, 2015
Q2 2015 51.3 Jun 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.